HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Triggering Receptor Expressed on Myeloid Cells-1 Agonist Regulates Intestinal Inflammation via Cd177+ Neutrophils.

Abstract
Triggering receptor expressed on myeloid cell-1 (TREM-1) signaling is expressed on neutrophils and monocytes that is necessary for the successful antimicrobial response and resolution of inflammation in the gut. In this study, we determined the effect of an anti-TREM-1 agonistic antibody (α-TREM-1) on colitis and identify its underlying mechanism of action. Administration of α-TREM-1 alleviated colitis in mice and resolved dysbiosis, which required TLR4/Myd88 signaling. α-TREM-1 increased the production of neutrophil extracellular traps and interleukin-22 by CD177+ neutrophils, which led to pathogen clearance and protection of the intestinal barrier. TREM-1 activation using an α-TREM-1 antibody protects against colitis by rebalancing the microbiota and protecting the epithelium against the immune response as well as modulates the function of neutrophils and macrophages. These results highlight the importance of the TREM-1 pathway in intestinal homeostasis and suggest that α-TREM-1 treatment may be an effective therapeutic strategy for inflammatory bowel disease.
AuthorsDong Hyuk Seo, Xiumei Che, Soochan Kim, Da Hye Kim, Hyun Woo Ma, Jae Hyeon Kim, Tae Il Kim, Won Ho Kim, Seung Won Kim, Jae Hee Cheon
JournalFrontiers in immunology (Front Immunol) Vol. 12 Pg. 650864 ( 2021) ISSN: 1664-3224 [Electronic] Switzerland
PMID33767714 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2021 Seo, Che, Kim, Kim, Ma, Kim, Kim, Kim, Kim and Cheon.
Chemical References
  • Antibodies
  • Cd177 protein, mouse
  • GPI-Linked Proteins
  • Interleukins
  • Isoantigens
  • Receptors, Cell Surface
  • Triggering Receptor Expressed on Myeloid Cells-1
Topics
  • Animals
  • Antibodies (immunology, pharmacology)
  • Colitis (immunology, metabolism, prevention & control)
  • Dysbiosis (microbiology, prevention & control)
  • Extracellular Traps (drug effects, immunology)
  • GPI-Linked Proteins (immunology, metabolism)
  • Gastrointestinal Microbiome (drug effects, immunology)
  • Inflammation (immunology, metabolism, prevention & control)
  • Inflammatory Bowel Diseases (immunology, metabolism, prevention & control)
  • Interleukins (immunology, metabolism)
  • Intestines (drug effects, immunology, pathology)
  • Isoantigens (immunology, metabolism)
  • Mice, Inbred BALB C
  • Mice, Inbred C57BL
  • Mice, Knockout
  • Neutrophils (drug effects, immunology, metabolism)
  • Receptors, Cell Surface (immunology, metabolism)
  • Triggering Receptor Expressed on Myeloid Cells-1 (agonists, immunology)
  • Interleukin-22
  • Mice

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: